2020•Osteoarthritis and CartilageOpen access

Study design of a phase 2 clinical trial with a disease-modifying Osteoarthritis drug candidate GLPG1972/S201086: The roccella trial

E. vanderAar, Henri Deckx, M. van der Stoep, M. Wooning, Katy Bernard, Sergey Grankov, Olivier Imbert, María Pueyo, F. Eckstein

Open full text 10 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

Open-access reader

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 10 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Medicine, Osteoarthritis, Aggrecan, ADAMTS, Placebo, Internal medicine, Cartilage, Synovial fluid

Back to paper search Browse research topics Original source

Study design of a phase 2 clinical trial with a disease-modifying Osteoarthritis drug candidate GLPG1972/S201086: The roccella trial — Research Paper | ScholarLens